These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31877123)

  • 81. D-Amino Acid Substitution of Peptide-Mediated NF-κB Suppression in mdx Mice Preserves Therapeutic Benefit in Skeletal Muscle, but Causes Kidney Toxicity.
    Reay DP; Bastacky SI; Wack KE; Stolz DB; Robbins PD; Clemens PR
    Mol Med; 2015 May; 21(1):442-52. PubMed ID: 26018805
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Restoration of pharyngeal dilator muscle force in dystrophin-deficient (mdx) mice following co-treatment with neutralizing interleukin-6 receptor antibodies and urocortin 2.
    Burns DP; Rowland J; Canavan L; Murphy KH; Brannock M; O'Malley D; O'Halloran KD; Edge D
    Exp Physiol; 2017 Sep; 102(9):1177-1193. PubMed ID: 28665499
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles?
    Niebrój-Dobosz I; Fidziańska A; Glinka Z; Hausmanowa-Petrusewicz I
    Folia Neuropathol; 2002; 40(3):143-50. PubMed ID: 12572920
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Inhibition of sphingolipid de novo synthesis counteracts muscular dystrophy.
    Laurila PP; Luan P; Wohlwend M; Zanou N; Crisol B; Imamura de Lima T; Goeminne LJE; Gallart-Ayala H; Shong M; Ivanisevic J; Place N; Auwerx J
    Sci Adv; 2022 Jan; 8(4):eabh4423. PubMed ID: 35089797
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Taurine deficiency, synthesis and transport in the mdx mouse model for Duchenne Muscular Dystrophy.
    Terrill JR; Grounds MD; Arthur PG
    Int J Biochem Cell Biol; 2015 Sep; 66():141-8. PubMed ID: 26239309
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.
    D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ
    Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Paeonia lactiflora extract improves the muscle function of mdx mice, an animal model of Duchenne muscular dystrophy, via downregulating the high mobility group box 1 protein.
    Sim I; Jang J; Song J; Lee J; Lim H; Lee HJ; Hwang G; Kwon YV; Lee D; Yoon Y
    J Ethnopharmacol; 2022 May; 289():115079. PubMed ID: 35149132
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy.
    Uaesoontrachoon K; Quinn JL; Tatem KS; Van Der Meulen JH; Yu Q; Phadke A; Miller BK; Gordish-Dressman H; Ongini E; Miglietta D; Nagaraju K
    Hum Mol Genet; 2014 Jun; 23(12):3239-49. PubMed ID: 24463621
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy.
    Reutenauer J; Dorchies OM; Patthey-Vuadens O; Vuagniaux G; Ruegg UT
    Br J Pharmacol; 2008 Oct; 155(4):574-84. PubMed ID: 18641676
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Dental pulp stem cells can improve muscle dysfunction in animal models of Duchenne muscular dystrophy.
    Nitahara-Kasahara Y; Kuraoka M; Guillermo PH; Hayashita-Kinoh H; Maruoka Y; Nakamura-Takahasi A; Kimura K; Takeda S; Okada T
    Stem Cell Res Ther; 2021 Jan; 12(1):78. PubMed ID: 33494794
    [TBL] [Abstract][Full Text] [Related]  

  • 91. BETs inhibition attenuates oxidative stress and preserves muscle integrity in Duchenne muscular dystrophy.
    Segatto M; Szokoll R; Fittipaldi R; Bottino C; Nevi L; Mamchaoui K; Filippakopoulos P; Caretti G
    Nat Commun; 2020 Nov; 11(1):6108. PubMed ID: 33257646
    [TBL] [Abstract][Full Text] [Related]  

  • 92. miR-378 affects metabolic disturbances in the mdx model of Duchenne muscular dystrophy.
    Podkalicka P; Mucha O; Kaziród K; Szade K; Stępniewski J; Ivanishchuk L; Hirao H; Pośpiech E; Józkowicz A; Kupiec-Weglinski JW; Dulak J; Łoboda A
    Sci Rep; 2022 Mar; 12(1):3945. PubMed ID: 35273230
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.
    Kornegay JN; Spurney CF; Nghiem PP; Brinkmeyer-Langford CL; Hoffman EP; Nagaraju K
    ILAR J; 2014; 55(1):119-49. PubMed ID: 24936034
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A comparison of the bone and growth phenotype of
    Wood CL; Suchacki KJ; van 't Hof R; Cawthorn WP; Dillon S; Straub V; Wong SC; Ahmed SF; Farquharson C
    Dis Model Mech; 2020 Jan; 13(2):. PubMed ID: 31754018
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Investigating the Potential for Sulforaphane to Attenuate Gastrointestinal Dysfunction in
    Swiderski K; Read SJ; Chan AS; Chung JD; Trieu J; Naim T; Koopman R; Lynch GS
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34960110
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Inhibition of PKCθ Improves Dystrophic Heart Phenotype and Function in a Novel Model of DMD Cardiomyopathy.
    Morroni J; Schirone L; Valenti V; Zwergel C; Riera CS; Valente S; Vecchio D; Schiavon S; Ragno R; Mai A; Sciarretta S; Lozanoska-Ochser B; Bouchè M
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216371
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Reduced Sarcolemmal Membrane Repair Exacerbates Striated Muscle Pathology in a Mouse Model of Duchenne Muscular Dystrophy.
    Paleo BJ; McElhanon KE; Bulgart HR; Banford KK; Beck EX; Sattler KM; Goines BN; Ratcliff SL; Crowe KE; Weisleder N
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563723
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The pan HDAC inhibitor Givinostat improves muscle function and histological parameters in two Duchenne muscular dystrophy murine models expressing different haplotypes of the LTBP4 gene.
    Licandro SA; Crippa L; Pomarico R; Perego R; Fossati G; Leoni F; Steinkühler C
    Skelet Muscle; 2021 Jul; 11(1):19. PubMed ID: 34294164
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Photobiomodulation Therapy for Attenuating the Dystrophic Phenotype of Mdx Mice.
    Macedo AB; Mizobuti DS; Hermes TA; Mâncio RD; Pertille A; Kido LA; Cagnon VHA; Minatel E
    Photochem Photobiol; 2020 Jan; 96(1):200-207. PubMed ID: 31733143
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Histological Analysis of Tibialis Anterior Muscle of DMDmdx4Cv Mice from 1 to 24 Months.
    Ben Larbi S; Saclier M; Fessard A; Juban G; Chazaud B
    J Neuromuscul Dis; 2021; 8(4):513-524. PubMed ID: 33843691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.